Drug Nutrition Interactions provides reliable drug info focused on nutritional effects for dietitians & other professionals, anytime, anywhere. Subscribe now to DNI expert #pharmacist and #dietitian curated content at https://t.co/kiyDDpbwU1
Student pricing available! 💊🍏🔥
Had a great conversation with Dr Kristen Hicks-Roof on the Nutrition Connections podcast! Biggest theme: advancing interprofessional collaboration, a concept at the heart of Drug Nutrition Interactions with curated recommendations from Dr Mary Litchford https://t.co/OC9Zmj7luy
Clinical trials are still needed. May eventually consider how coffee's bioactive profile fits into individualized nutrition plans, particularly for clients seeking non-pharmacologic tools to complement standard care for Type 2 diabetes.
Discovery: 3 new compounds in roasted coffee that strongly inhibit alpha-glucosidase (enzyme which breaks down CHOs into absorbable sugars) which may ▼ rate of glucose absorption, mitigating post-meal glycemic spikes.
https://t.co/FeNRgzdEpr
🚀 Coming in 2026:
📚 Presenting/sponsoring at NDEP (March)
🎙️ Presenting Ohio AND (April)
💊 40+ new drugs/100s of real‑time safety updates
Thanks to subscribers, educators, students & interns who made 2025 our best year yet
👉 Try DNI free for 7 days: https://t.co/thaOqkhDDR
🎉2025 Year in Review!🎉
What a year for medication–nutrition safety with DNI!
📈 623 new subscribers
🎤 FNCE Nashville + NDEP Memphis
💊 50 new drugs added
⚠️ 687 real‑time drug warning/indication updates (print versions can never keep up)
🏫 50+ dietetics programs adopted DNI, including largest in the US, University of New England @unetweets
🎙️ Featured on multiple Ask the Pharmacist episodes of My Wife the Dietitian
Non–HDL-C, apolipoprotein B, and lipoprotein(a) also improved & treatment was well tolerated.
Nutrition remains a foundational approach but many HeFH patients struggle to reach LDL-C targets. An oral PCSK9 inhibitor could simplify adherence as a powerful adjunct to diet changes
A recent phase 3 RCT evaluated the oral PCSK9 inhibitor enlicitide, in adults with heterozygous familial hypercholesterolemia (HeFH) already taking a statin, resulting in a 58% ▼ in LDL-C at 24 weeks c/w placebo, with sustained efficacy at 1 year.
https://t.co/EmA1dHTixx
Resignation of veteran cancer researcher and elevation of inexperienced political appointee to chairman of the FDA Centre for Drug Evaluation and Research characterized as “extinction level event” per agency source https://t.co/v60JyxErgj
The pendulum swings back -- FDA planning to remove 'Black Box' safety warning from hormone replacement therapy (HRT) for menopause applied in 2003
https://t.co/8TFrwu926W
🫀Nutrition matters in Long QT (LQT) Syndrome. Emerging research shows diet can modulate arrhythmia risk, especially genotypes like LQT1 & LQT2.
✅ Balanced meals=stable QT
⚡Potassium may help LQT2
🚫Licorice, energy drinks, grapefruit may ▲ risk
#Dietitians play a key role
High-intensity statins ▼ CVD risk but may ▲ T2DM risk—especially with ▲ BMI. Boosting CV fitness via physical activity helps ▼ this risk. Lifestyle=configured for balanced health!
https://t.co/sCCiPbXOjK
You don't have to have attended the Academy of Nutrition and Dietetics FNCE meeting in Nashville to get a *FREE* 7-day trial of Drug Nutrition Interactions -- our trial is open to everyone! Start your trial today at https://t.co/thaOqkhDDR
You don't have to have attended the @eatrightPRO Academy of Nutrition and Dietetics FNCE meeting in Nashville to get a *FREE* 7-day trial of Drug Nutrition Interactions @dninteractions -- our trial is open to everyone! Start your trial today at https://t.co/thaOqkhDDR
Last day at FNCE Nashville Y’all! If you haven’t visited the Drug Nutrition Interactions booth #940 in the Expo hall yet, make sure to stop by and see us this morning.
Today is the day y’all! Drug Nutrition Interactions senior dietitian Mary Litchford PHD, RDN, LDN is delivering her Distinguished Lecture “The Ovelooked Patient” today at 3:30 pm.
Heading to Nashville for the #FNCE meeting this coming weekend? Come visit @DrDeanElbe at the Drug Nutrition Interactions booth #940 in the Expo Hall and let us know how you have incorporated DNI into your training and/or practice!